Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug aims to curb meth's grip in non-treatment seekers

NCT ID NCT06721494

First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 18 times

Summary

This study tests a new medicine called CS-1103 in 40 healthy adults who use methamphetamine but are not looking for treatment. The goal is to see if CS-1103 can safely reduce the drug's effects and help the body get rid of meth faster. Participants receive a single dose of methamphetamine followed by CS-1103, and researchers monitor safety and how the drug works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE ABUSE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • California Clinical Trials Medical Group

    RECRUITING

    Glendale, California, 91206, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.